With this background the aim of the study was to compare prevalence of MS evaluated through the different classifications (mainly CKM, ATP-III, and IDF) in patients with essential hypertension, focusing on differences on pressure profile and subclinical organ damage in different groups. This evidence concerns the gene CKM and myeloid sarcoma.